Up to 70% of first Zepbound prior authorization requests come back denied. Fewer than 1 in 10 patients ever appeal. Yet more than 65% of properly documented appeals win. Most “ask your doctor” articles never walk the paperwork, the peer-to-peer call, or what to do when your PBM drops the drug mid-titration.
This guide covers how to get Zepbound end to end, in the order the decisions actually happen. It walks the prior auth flow, names which telehealth providers route brand-name Zepbound versus only compounded, and surfaces three 2026 facts most guides get wrong:
- Lilly Cares does not cover Zepbound. Patients sent there for “free Zepbound” get rejected.
- The Medicare GLP-1 Bridge launches July 1, 2026 at about $50/month for the KwikPen only.
- LillyDirect is now $449/month flat for every dose from 7.5mg through 15mg. Titrating up costs nothing extra.
We also walk what no other guide covers: the actual LillyDirect unboxing, the Walmart pharmacy pickup option launched October 29, 2025 (2 to 5 days, no shipping wait), what to do when your PBM drops Zepbound mid-titration (CVS Caremark did this July 2025), and how to use the December 2024 OSA indication as an insurance unlock at BMI 27 to 29.
Eight sequential steps follow, from qualifying through what to do if Zepbound is genuinely off the table. Start with confirming you actually qualify.
Step 1: Confirm You Qualify (Three Doors, Not One)
There are three ways to qualify for Zepbound, not one. The third one, obstructive sleep apnea at BMI 27 or higher, is the only door Medicare currently pays through.
The three doors:
- BMI 30 or higher under the chronic weight management indication (FDA approved December 2023).
- BMI 27 or higher with one comorbidity: type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.
- BMI 27 or higher with moderate-to-severe OSA, a separate FDA indication added December 2024. Requires polysomnography showing an apnea-hypopnea index (AHI) of at least 15 events per hour for severe, or at least 5 events per hour with documented daytime sleepiness for moderate.
Door #3 is the one most articles bury, and it changes your insurance argument. Cigna explicitly favors the OSA indication for Zepbound approval. Medicare Part D may cover Zepbound under the OSA indication even though Medicare does not cover it for weight loss at all. UnitedHealthcare has the highest overall Zepbound approval rate among major commercial carriers.
If your BMI sits between 27 and 29 and you have never been tested for sleep apnea, ask now. Snoring, waking up tired, morning headaches, and hypertension are common cues. A home sleep apnea test can document the AHI you need without an overnight lab visit, and the December 2024 OSA indication does not require any weight-loss justification on the chart. Code your future PA submission to ICD-10 G47.33 if the result confirms moderate-to-severe OSA.
Leave this step knowing exactly which of the three doors you are walking through. That single choice determines your insurance argument later in Step 5, your provider’s chart documentation in Step 3, and whether Medicare patients have a path before July 2026.
Step 2: Pick Your Access Path
The fastest route from decision to first injection is 2 to 5 days via LillyDirect with Walmart pickup. The slowest is 6 to 12 weeks if you go through insurance and get denied. Pick your path based on which trade-off you can live with.
1. Insurance plus your doctor (commercial PA path). 2 to 3 weeks minimum if approved on the first try. 4 to 12 weeks if denied and appealed. Cheapest if approved, often as low as $25 per month with the Zepbound Savings Card. Best for anyone whose plan still covers Zepbound.
2. LillyDirect self-pay via Gifthealth or Walmart pickup. 3 to 10 days for home delivery, 2 to 5 days via Walmart pharmacy pickup. Flat pricing: $299/month for 2.5mg, $399/month for 5mg, $449/month for every dose from 7.5mg through 15mg. Best for uninsured patients, patients on plans that exclude Zepbound (CVS Caremark dropped it July 2025), or anyone who values speed over savings.
3. Telehealth plus insurance or cash. 3 to 7 days for the visit, plus whichever fulfillment path you choose. Best for patients without a regular PCP or anyone who wants a provider to handle the PA paperwork. Brands that prescribe brand-name Zepbound include Ro (the only one identified that runs the full PA cycle including denial management), PlushCare (bills commercial insurance for the visit at roughly a $30 copay for Aetna, BCBS, Anthem, Humana, and Medicare), MedVi ($99/month membership), Mochi Health (specialist-led with insurance, but verify the current pharmacy partner since Aequita shut down), Walgreens Weight Management ($49 visit, cash only, no PA help), and GoodRx Care ($39/month plus the $299 LillyDirect routing). For a side-by-side look at telehealth providers across brand-name and compounded paths, see our telehealth comparison.
One callout that saves you a wasted enrollment: Peak Wellness, Eden, Embody, and Henry Meds do not prescribe brand-name Zepbound. They are compounded-only. If brand is what you want, skip them.
If you picked path 1, your next stop is the doctor visit. If you picked path 2 or 3, you still need a prescription, which Step 3 covers either way.
Step 3: Get the Prescription
The single biggest reason insurance denies Zepbound is that your chart did not say the right thing during this exact appointment. Documentation completeness, not clinical eligibility, kills most PAs.
Before you sit down with the prescriber, call your insurance company. Use this script: “Hi, I’m calling to check coverage for a medication called Zepbound (tirzepatide) for chronic weight management. I’d like to understand the prior authorization requirements.” Ask specifically about step therapy. Note the criteria they cite, the rep’s name, and a reference number.
Bring or have ready:
- Current measured BMI from height and weight taken that day, not a self-report.
- Diagnosis dates and ICD-10 codes for every comorbidity that applies: T2D, hypertension, dyslipidemia, OSA (G47.33), cardiovascular disease.
- 3 to 6 months of structured lifestyle intervention records: food log, gym check-ins, dietitian notes, weight-loss program records.
- History of prior weight-loss medications you have tried, with names, dates, outcomes, and the reason you stopped.
- For the OSA path: the polysomnography or home sleep test report with the AHI number visible.
In the visit, ask your provider to document specifics, not generalities. Exact BMI as a number, formal diagnosis with the ICD-10 code, structured intervention with dates. “BMI elevated, has tried diet and exercise” gets denied. “BMI 34.2 measured today, completed 12-week medically supervised program at [clinic] Jan-Mar 2026, ICD-10 E66.01” gets approved.
If you went the telehealth route in Step 2, the provider runs this visit for you. Ro and Mochi build chart documentation to PA standard. Walgreens Weight Management does not, since it is cash-only by design and does not file insurance.
Avoid this common mistake: letting your provider write “BMI elevated” instead of the actual number. Vague chart language is the number one driver of preventable Zepbound denials.
Step 4: Fill It (LillyDirect, Retail, or Walmart Pickup)
Most articles end at “your prescription gets filled.” The actual experience, what shows up in the box, how cold it still is, whether you can skip shipping by picking up at Walmart, determines whether your first month goes smoothly.
Three fulfillment routes exist in May 2026:
1. LillyDirect via Gifthealth (home delivery). Your prescriber sends the Rx to Gifthealth. You complete checkout, Gifthealth ships within 1 to 3 days, and the cold-pack box arrives 1 to 4 days after that. Pricing is flat at $299 (2.5mg), $399 (5mg), and $449 (7.5mg-15mg) for both vials and KwikPens.
2. LillyDirect via Walmart pharmacy pickup. Launched October 29, 2025 as the first LillyDirect retail partnership. Same prices as home delivery. Order is ready in 24 to 48 hours at a participating Walmart pharmacy. No shipping wait, no cold-pack guesswork. You walk in and pick it up.
3. Retail pharmacy on insurance. Your provider sends the Rx to your preferred pharmacy. With PA approval and the Zepbound Savings Card layered on top, you can land at $25/month. Without insurance, single-dose-pen retail pricing can exceed $1,086/month at some pharmacies, which is why LillyDirect cash is almost always the better self-pay option.
What actually arrives in a LillyDirect box: a refrigerated cold-pack carton, your KwikPens or vials, needles, alcohol swabs, and a paper insert. Patient unboxings posted on YouTube through late 2025 match the official Gifthealth documentation.
Cold-chain storage rules:
- Refrigerator: 36 to 46 degrees Fahrenheit, in the original carton, protected from light.
- Single-dose pens and vials: tolerate up to 86 degrees Fahrenheit for 21 days, one time only, then discard.
- KwikPen unopened: tolerates up to 86 degrees for up to 30 days.
- KwikPen after first use: a 21-day room-temperature clock starts from your first injection.
- Never freeze. Never return a pen to the fridge after room-temp storage has started.
If your package arrives warm, do not inject. Call Gifthealth or LillyDirect first. They will tell you whether the medication is still viable and replace it if not.
Direct recommendation: if you live near a participating Walmart pharmacy, the pickup option is the lowest-friction fill. 24 to 48 hours, no shipping wait, no cold-pack worry, same price.
Step 5: Run the Prior Authorization (and Appeal If Denied)
Up to 70% of first Zepbound PAs are denied. Yet over 65% of properly documented appeals succeed, and fewer than 1 in 10 denied patients ever appeals. The appeal is the step nobody tells you about, and it is the one that wins.
Under the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), effective in 2026, insurers must respond to urgent PA requests within 72 hours and standard requests within 7 days. If you have not heard back in 5 business days, have your provider’s office call.
If the first decision is a denial, run this 4-step appeal protocol:
- Get the denial reason in writing. You have 180 days from the denial letter date to appeal. Each appeal has to address the reason directly.
- Request a peer-to-peer review immediately. Your prescriber calls the insurer’s medical director. It has the highest single-step success rate of any appeal type. Ask the provider’s office to schedule it the same day you receive the denial.
- File a written appeal addressing each denial reason. If the denial cited missing BMI documentation, attach a dated BMI record. If it cited no lifestyle intervention, attach 3 to 6 months of structured records. Reference the insurer’s coverage criteria line by line and show how you meet each one.
- External independent review if the internal appeal fails. The ACA requires this option for commercial plans. A third-party reviewer takes a fresh look at the case.
Common denial reasons and the fix for each:
- BMI not documented at threshold. Attach a measured BMI record dated within the last 90 days.
- Comorbidity not formally diagnosed. Get the formal diagnosis with the ICD-10 code added to the chart, then resubmit.
- Lifestyle intervention not documented for 3-6 months. Attach food log, gym records, dietitian visit notes covering the window.
- Step therapy not completed. Request a step therapy exception with documented contraindication, or document past trials from your medical history.
The step therapy trap deserves its own name. Some insurers require you to fail phentermine, orlistat, contrave, or topiramate first. That adds 4 to 12 weeks or more before Zepbound is even on the table. Exception requests work when you have a contraindication, and many providers can document prior trials from your medical history without putting you through them again.
Plan for PA approval within 3 weeks if your first submission lands clean, or 6 to 10 weeks if you run peer-to-peer plus a written appeal. Both timelines beat giving up. Stack the Zepbound Savings Card on top, covered in Step 6, and your copay can drop as low as $25 per month.
Step 6: Cut Your Cost (Savings Card, Medicare Bridge, and the Lilly Cares Myth)
Three things to know about cost in 2026. The Zepbound Savings Card can bring your copay to $25/month. Medicare’s GLP-1 Bridge launches July 1, 2026 at about $50/month for the KwikPen. Lilly Cares, the program competitor articles keep recommending, does not cover Zepbound.
1. Zepbound Savings Card (commercial insurance only).
- Copay as low as $25/month when your insurance covers Zepbound.
- Up to $1,300 in annual savings, up to 13 fills per year.
- Per-fill caps: $100 (1-month supply), $200 (2-month), $300 (3-month).
- Enroll at zepbound.lilly.com. No coupon code needed.
- Valid through December 31, 2026.
- Not available to Medicare or Medicaid beneficiaries. Federal anti-kickback statute, not a Lilly policy choice.
2. Medicare GLP-1 Bridge Program (launches July 1, 2026).
- Covers the Zepbound KwikPen at approximately $50/month for eligible Medicare beneficiaries.
- KwikPen only. Vials and single-dose pens are not covered under the Bridge.
- Runs July 1 through December 31, 2026, with a possible extension into 2027.
- Until July 1, Medicare patients with OSA and BMI 27 or higher can already qualify for Zepbound coverage under Medicare Part D using the OSA indication.
3. The Lilly Cares correction.
- Lilly Cares Foundation does not cover Zepbound as of April 2026.
- Zepbound is not on the Lilly Cares medication list.
- Multiple competing how-to articles still tell low-income uninsured patients to apply to Lilly Cares for free Zepbound. They will be rejected.
- For low-income uninsured patients, the real options are LillyDirect self-pay starting at $299/month for 2.5mg, or compounded tirzepatide as a fallback at $179 to $349/month (Step 8).
Cost-stacking in plain terms. Insurance plus PA approval plus Savings Card equals the $25/month best case. LillyDirect cash plus Walmart pickup equals the $299 to $449/month no-friction case. There is no real middle ground for most patients.
Avoid this common mistake: do not waste a week applying to Lilly Cares for Zepbound. It does not cover this drug. Spend that week filing your PA appeal or switching to LillyDirect instead.
Step 7: Protect Your Supply If Your Insurance Changes
The most common Zepbound horror story is not a denied PA. It is losing coverage mid-titration. Your PBM drops the drug in a rebate deal, your employer swaps plans at open enrollment, you change jobs. CVS Caremark did exactly this to Zepbound patients in July 2025.
Recent precedents so you know this is normal, not personal:
- CVS Caremark dropped Zepbound from most formularies July 1, 2025 after a rebate deal with Wegovy’s manufacturer.
- BCBS Massachusetts, Health New England, and Kaiser are dropping or restricting GLP-1 weight-loss coverage for the 2026 plan year. More PBM moves are expected as employer renewals roll through.
The 5-step bridge protocol:
- Confirm the change in writing. Get the formulary letter and the effective date. You usually have weeks before coverage actually ends.
- Stock up on your last covered fill. Ask your prescriber for a 90-day supply if your current plan allows it. Lock in cost before the cutoff.
- Switch to LillyDirect self-pay. Fastest pivot. $299 to $449/month flat, uses your existing prescription, no new PA. Call Gifthealth or go to lilly.com/lillydirect.
- Request a formulary exception from your new insurer. Cite ongoing treatment, clinical necessity, and document the progress you have already made. New plans approve exceptions more often than first denials suggest, especially with treatment continuity language.
- Check the Medicare Bridge if you have become Medicare-eligible. The July 1, 2026 launch covers the KwikPen at roughly $50/month.
503A compounded tirzepatide can bridge while insurance gets resolved. Cheaper at $179 to $349/month, legally uncertain as of mid-2026. Step 8 covers it in full.
Do not dose-stretch. Extending the interval between injections to make supply last longer gets discussed in patient communities, but it is not FDA-recommended. You risk losing therapeutic effect and triggering rebound hunger. Pay cash through LillyDirect or move to compounded instead.
Step 8: If You Can’t Get Zepbound: The Compounded Tirzepatide Alternative
A parallel market for tirzepatide runs at $179 to $349/month, compounded by specialty pharmacies. As of May 2026, it is legal but under direct FDA pressure. Here is what is real, what is risky, and which providers patient testing rates highest on lived experience.
Zepbound is not accessible for everyone. Uninsured patients without $299/month, denied-and-out-of-appeals patients, Medicare patients without an OSA diagnosis before July 2026, and patients dropped mid-treatment all face the same question. Compounded tirzepatide is the real answer for many of them.
The 2026 legal context:
- FDA proposed a rule on April 30, 2026 to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List.
- Comment period closes June 29, 2026. The rule is not yet finalized.
- If finalized, it would end large-scale 503B outsourcing-facility compounding of tirzepatide.
- 503A pharmacies (individual patient prescriptions, smaller scale) may continue under separate legal authority, though supply would tighten and prices would likely rise.
- FDA cited 320+ adverse event reports from compounded tirzepatide as the basis for the proposal.
What to look for in a compounded tirzepatide provider: pharmacy partner disclosed before signup, a real cancel button (not one that pretends), cold-chain packaging that arrives still cold, transparent refund policy, no pending FDA warning letters against the partner pharmacy.
Real patient-experience signals from intake testing on the major providers:
- Pomegranate scores 97/100 on Patient Support and 100/100 on Medication Handling. Top-tier on lived experience.
- ShedRx scores 92/100 on PS and 100/100 on MH. Strong, clean handling.
- Mochi scores 100/100 on both axes, but documented billing-trap concerns exist. Verify cancellation terms before subscribing. Water-bottle-style packaging design noted in testing.
- GobyMeds scores 97 on PS and 50 on MH. Notable for disclosing its pharmacy partner before signup, which most providers do not.
- Avoid: RemedyMeds received an FDA warning letter in September 2025. Enhance.MD has a fake cancel button that does not actually cancel. Lemonaid shipments have arrived with melted ice packs in intake testing.
Compounded tirzepatide is a real option for patients shut out of Zepbound. The legal ground may shift in late 2026. If brand-name Zepbound becomes accessible through insurance, the Bridge Program, or LillyDirect cash, that is the more durable path.
Frequently Asked Questions
Can I get Zepbound online without seeing a doctor in person?
Yes. Telehealth providers that prescribe brand-name Zepbound include Ro (full PA support), PlushCare (insurance-billed visits), Mochi Health (specialist-led, verify pharmacy partner), MedVi ($99/month), Walgreens Weight Management ($49, cash only), and GoodRx Care ($39/month plus LillyDirect routing).
Does Medicare cover Zepbound in 2026?
Not for weight loss. Medicare Part D may cover Zepbound for moderate-to-severe OSA with BMI 27 or higher. The Medicare GLP-1 Bridge Program launches July 1, 2026, covering the KwikPen at about $50/month for eligible beneficiaries. Medicare patients cannot use the Savings Card.
Does Lilly Cares cover Zepbound?
No. As of April 2026, Zepbound is not on the Lilly Cares Foundation medication list. Despite what some competitor articles still claim, no free-drug patient assistance program exists for Zepbound. LillyDirect self-pay starts at $299/month for the 2.5mg dose.
How long does it take to get Zepbound from first decision to first injection?
LillyDirect cash takes 3 to 10 days, or 2 to 5 days with Walmart pickup. The insurance and PA path takes 2 to 3 weeks if approved on the first try, and 6 to 12 weeks if denied and appealed.
My insurance denied Zepbound. What do I do?
Request the denial reason in writing, then ask your doctor for a peer-to-peer review (highest success rate). File a written appeal addressing each denial reason within 180 days. Over 65% of properly documented appeals succeed, yet fewer than 1 in 10 patients ever appeals.
Can I qualify for Zepbound with a BMI under 30?
Yes, two ways. BMI 27 or higher with a comorbidity (T2D, hypertension, dyslipidemia, OSA, cardiovascular disease) qualifies under the weight-loss indication. BMI 27 or higher with moderate-to-severe OSA qualifies under the separate OSA indication added December 2024.
Is compounded tirzepatide still legal in 2026?
As of May 2026, yes, but under direct regulatory pressure. The FDA’s April 30, 2026 proposed rule would exclude tirzepatide from the 503B bulks list. The comment window closes June 29, 2026. 503A pharmacies may continue under separate authority. Monitor regulatory status closely.
Does Zepbound need refrigeration? What if my package arrives warm?
Yes, 36 to 46 degrees Fahrenheit. Single-dose pens and vials tolerate up to 86 degrees for 21 days (one time only). KwikPens tolerate up to 86 degrees for 30 days before first use. Never freeze. If your package arrives warm, call Gifthealth or LillyDirect before injecting.